Plasma levels of CTSD (Cathepsin D) have been suggested as a biomarker for IR as they correlate with IR, and are associated with insulin sensitivity and hepatic inflammation [56–59], and have also been reported as a potential diagnostic biomarker for AD and Parkinson's disease [60, 61]. This evidence concerns the gene INS and Alzheimer disease.